Morgan Stanley raised the firm’s price target on Veeva (VEEV) to $222 from $210 and keeps an Underweight rating on the shares. Veeva beat revenue and EPS expectations in Q2 and guided above for Q3, but “the bar was arguably higher” following strong outperformance since the last earnings report and billings performance “may underwhelm,” the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV: